David S Baldwin
Overview
Explore the profile of David S Baldwin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
237
Citations
3248
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Huneke N, Fusetto Veronesi G, Garner M, Baldwin D, Cortese S
JAMA Psychiatry
. 2025 Mar;
PMID: 40072447
Importance: Expectancy effects are significant confounding factors in psychiatric randomized clinical trials (RCTs), potentially affecting the interpretation of study results. This narrative review is the first, to our knowledge, to...
2.
Pini S, Milrod B, Nardi B, Massimetti G, Bonelli C, Baldwin D, et al.
J Affect Disord
. 2025 Mar;
PMID: 40058467
Background: Anhedonia is psychopathological dimension conceptualized as loss of pleasure in several activities. Although typically viewed as a characteristic feature of depressive episodes, anhedonic experience is also seen in other...
3.
4.
Ioannidis K, Huneke N, Solly J, Fusetto Veronesi G, Tzagarakis C, Parlatini V, et al.
Acta Neuropsychiatr
. 2024 Nov;
:1-11.
PMID: 39563187
Background: Placebo and nocebo effects are widely reported across psychiatric conditions, yet have seldom been examined in the context of gambling disorder. Through meta-analysis, we examined placebo effects, their moderating...
5.
Critchley H, Tracy D, Malhi G, Alexander L, Baldwin D, Cavanagh J, et al.
Br J Psychiatry
. 2024 Oct;
225(6):521-525.
PMID: 39411847
This editorial considers the value and nature of academic psychiatry by asking what defines the specialty and psychiatrists as academics. We frame academic psychiatry as a way of thinking that...
6.
Henry R, Baldwin D
Ther Adv Psychopharmacol
. 2024 Sep;
14:20451253241247368.
PMID: 39314213
Background: The benefit of generalist pharmacists working within primary care networks (PCNs) and with general practitioners (GPs) is established. We wished to evaluate the contributions and potential benefits of a...
7.
Bates A, Baldwin D, Pattison N, Moyses H, Huneke N, Cortese S, et al.
Cochrane Database Syst Rev
. 2024 Jul;
7:CD015640.
PMID: 39041417
Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the effects of eye movement desensitisation and reprocessing (EMDR), a psychological intervention programme,...
8.
Austin H, Chamberlain S, Grant J, Baldwin D
J Gambl Stud
. 2024 Jul;
40(4):2141-2151.
PMID: 39012447
Aims: To investigate the potential association between gambling disorder and symptoms of sleep problems (including insomnia and excessive daytime sleepiness). It was hypothesised that, compared to controls, individuals with gambling...
9.
Huneke N, Amin J, Baldwin D, Bellato A, Brandt V, Chamberlain S, et al.
Mol Psychiatry
. 2024 Jun;
29(12):3915-3925.
PMID: 38914807
There is a growing literature exploring the placebo response within specific mental disorders, but no overarching quantitative synthesis of this research has analyzed evidence across mental disorders. We carried out...
10.
Sabe M, Hyde J, Cramer C, Eberhard A, Crippa A, Brunoni A, et al.
JAMA Netw Open
. 2024 May;
7(5):e2412616.
PMID: 38776083
Importance: Noninvasive brain stimulation (NIBS) interventions have been shown to be efficacious in several mental disorders, but the optimal dose stimulation parameters for each disorder are unknown. Objective: To define...